MAR 25, 2019 9:04 AM PDT

Aspirin Combats Tuberculosis

WRITTEN BY: Nouran Amin

Tuberculosis is a global infection far from being eradicated. It currently infects more than 1,400 people per year in Australia. The deadliest form and expensive to treat is antibiotic resistant tuberculosis—costing about $250,000 to treat a single case.

Now, researchers at the Centenary Institute have been working on new treatments for tuberculosis by seeking to increase the effectiveness of the immune system. In particular, they found a brand new target for the treatment of drug-resistant tuberculosis. Through their understanding that the tuberculosis bacterium alters platelets from the body's blood clotting system to weaken the immune systems—scientists were able to use a zebrafish model of tuberculosis to observe the build-up of clots and activation of platelets on infected regions, using fluorescent microscopy.

"The zebrafish gives us literal insight into disease processes by watching cells interacting in real time,” says senior author and head of the Centenary's Immune-Vascular Interactions laboratory, Dr. Stefan Oehlers.

 

 

Green platelets sticking to red blood vessels next to sites of infection by blue bacteria. Pathogenic platelets are the green cells that stick next to the bacteria for a few minutes.

According to the study published in The Journal of Infectious Diseases, the platelets were found to be tricked by the infection by getting in to the way of the body's defense system. Therefore, they treated the sites of infection with anti-platelet drugs, including the most common form of aspirin. The aspirin was found to prevent the altercations of platelets and allowed the body to control the infection better.

"This is the first time that platelets have been found to worsen tuberculosis in an animal model. It opens up the possibility that anti-platelet drugs could be used to help the immune system fight off drug resistant TB,” says Dr. Elinor Hortle, lead author of the paper. "Our study provides more crucial evidence that widely available aspirin could be used to treat patients with severe tuberculosis infection and save lives.”

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
FEB 20, 2021
Drug Discovery & Development
Deep Brain Stimulation Offsets Epileptic Seizures
FEB 20, 2021
Deep Brain Stimulation Offsets Epileptic Seizures
Researchers from the University of Freiburg in Germany have found that deep brain stimulation (DBS) in the brain’s ...
MAR 18, 2021
Drug Discovery & Development
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
MAR 18, 2021
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to ta ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
MAY 14, 2021
Health & Medicine
A National Standard THC Dose for Researchers is Here
MAY 14, 2021
A National Standard THC Dose for Researchers is Here
    Whatever your stance on cannabis, almost  everyone would agree that more, better quality, research sh ...
MAY 22, 2021
Drug Discovery & Development
FDA Approves Trials for Ketamine to Treat Parkinson's
MAY 22, 2021
FDA Approves Trials for Ketamine to Treat Parkinson's
The US FDA has approved PharmaTher’s Investigational New Drug application to begin Phase 2 clinical trials for ket ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
Loading Comments...